Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Analgesic Modes in Minimally Invasive Esophagectomy
NCT05504265Phase 3Recruiting
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Start
- Oct 2022
- Primary completion
- Sep 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of flurbiprofen axetil in postoperative pain, sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Started Oct 2022; status: recruiting.
02
Drugs
flurbiprofen axetil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05504265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05504265.